Topiramate vs Semaglutide

Compare off-label weight loss pills vs GLP-1 injections

See Full Comparison

Quick Summary

Topiramate is an anticonvulsant sometimes used off-label for weight loss due to its appetite-suppressing effects, while Semaglutide is a GLP-1 receptor agonist specifically designed to reduce appetite and improve satiety. Semaglutide typically delivers significantly greater and more consistent weight loss results.

Side-by-Side Comparison

Feature Topiramate ⭐ Off-label Semaglutide ⭐ GLP-1
Rating
3.8/5
★★★☆☆
4.8/5
★★★★★
Weight Loss 5–10% 10–15%+
Mechanism Appetite suppression (CNS) Appetite & satiety hormones (GLP-1)
Usage Daily tablets Weekly injection
Approval Not approved for weight loss Approved for weight loss
Cost Low High ($800+)
Best for Budget-friendly option Maximum weight loss
Check Options
Details View Topiramate View Semaglutide

🏆 Winner: Semaglutide (for effectiveness)

Semaglutide significantly outperforms Topiramate in terms of weight loss and appetite control. However, Topiramate remains a viable option for users seeking a lower-cost, non-injectable alternative.

Pros & Cons

Topiramate
  • Low cost
  • Available in tablet form
  • Can reduce appetite

Cons: Off-label use, neurological side effects, lower effectiveness

Semaglutide
  • Highest weight loss results
  • Strong appetite suppression
  • Once-weekly dosing

Cons: High cost, requires injection

FAQ

Semaglutide is generally more effective, leading to 10–15%+ weight loss compared to 5–10% with Topiramate.

Topiramate can reduce appetite and cravings, although it is not officially approved for weight loss.

For users seeking maximum weight loss and consistent results, Semaglutide is often worth the higher cost.

Topiramate may cause neurological side effects such as brain fog and fatigue, while Semaglutide may cause nausea and digestive issues.

Yes, but switching medications should always be done under medical supervision.

Related Comparisons